Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Systemic Lupus Erythematosus Market Size study, by Treatment Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Antimalarials, Corticosteroids, Biologics, and Others), Route of Administration (Oral, Intravenous, and Others), and Regional Forecasts 2022-2028

  • BIZ4983372
  • 200 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Systemic Lupus Erythematosus Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2022-2028. An autoimmune disease is systemic lupus erythematosus (SLE). In this disorder, the immune system mistakenly destroys healthy tissue. Affected organs may include the kidneys, brain, skin, joints, and other tissues. SLE affects women around 10 times more frequently than it does males. At any age, anyone may be impacted. However, the majority of those afflicted are young women between the ages of 15 and 44. Chest discomfort, weariness, enlarged lymph nodes, and other symptoms are some of the warning signs and symptoms of this disorder. The main driver of the market is medical Advancements by Biopharmaceutical Companies in SLE and increasing Prevalence of Systemic Lupus Erythematosus. For instance, Belimumab is the first biological drug authorised for the treatment of Systemic Lupus Erythematosus (SLE), according to the research "Biologics in Systemic Lupus Erythematosus (SLE)" released in March 2022. (anti-BlyS). More recent studies demonstrate that supplementing the standard of care for lupus nephritis with belimumab increases the renal response rate. Other biological therapies targeting B cells (such as obinutuzumab, a newer generation anti-CD20), and the type I interferon pathway (such as anifrolumab), have also showed potential in randomized placebo-controlled clinical studies in SLE. Furthermore, The HealthWell Foundation, an independent non-profit that provides financial assistance to Americans without health insurance, announce that its fund for persons with Systemic Lupus Erythematosus has been reopened as of December 2020. (SLE). As a result, it is anticipated to stimulate market expansion overall throughout the anticipated period. However, high Cost of Treatment impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Systemic Lupus Erythematosus Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market share owing to increased awareness about the disease in the society and growing support towards biopharmaceutical manufacturers. However, APAC is fastest growing region due to changing lifestyle and growing population and increase in the adoption of advanced technologies in this region.

Major market players included in this report are:

GlaxoSmithKline

Bristl Myers Squibb Company

F. Hoffmann-La Roche AG

Pfizer Limited

Novartis AG

Sanofi SA

ImmuPharma PLC

AstraZeneca

Viatris Inc

Eli Lilly & Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

Antimalarials

Corticosteroids

Biologics

Others

By Route of Administration:

Oral

Intravenous

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Systemic Lupus Erythematosus Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Systemic Lupus Erythematosus Market, by region, 2020-2028 (USD Million)

1.2.2. Systemic Lupus Erythematosus Market, by Treatment Type, 2020-2028 (USD Million)

1.2.3. Systemic Lupus Erythematosus Market, by Route of Administration, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Systemic Lupus Erythematosus Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Systemic Lupus Erythematosus Market Dynamics

3.1. Systemic Lupus Erythematosus Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Medical Advancements by Biopharmaceutical Companies in SLE

3.1.1.2. Increasing Prevalence of Systemic Lupus Erythematosus

3.1.2. Market Challenges

3.1.2.1. High Cost of Treatment

3.1.2.2. Several Misconceptions and Social Stigmas

3.1.3. Market Opportunities

3.1.3.1. Rise in the research and development activities

3.1.3.2. Launch of effective therapies

Chapter 4. Global Systemic Lupus Erythematosus Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Systemic Lupus Erythematosus Market, by Treatment Type

6.1. Market Snapshot

6.2. Global Systemic Lupus Erythematosus Market by Treatment Type, Performance - Potential Analysis

6.3. Global Systemic Lupus Erythematosus Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Million)

6.4. Systemic Lupus Erythematosus Market, Sub Segment Analysis

6.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

6.4.2. Antimalarials

6.4.3. Corticosteroids

6.4.4. Biologics

6.4.5. Others

Chapter 7. Global Systemic Lupus Erythematosus Market, by Route of Administration

7.1. Market Snapshot

7.2. Global Systemic Lupus Erythematosus Market by Route of Administration, Performance - Potential Analysis

7.3. Global Systemic Lupus Erythematosus Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)

7.4. Systemic Lupus Erythematosus Market, Sub Segment Analysis

7.4.1. Oral

7.4.2. Intravenous

7.4.3. Other

Chapter 8. Global Systemic Lupus Erythematosus Market, Regional Analysis

8.1. Systemic Lupus Erythematosus Market, Regional Market Snapshot

8.2. North America Systemic Lupus Erythematosus Market

8.2.1. U.S. Systemic Lupus Erythematosus Market

8.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2028

8.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2028

8.2.2. Canada Systemic Lupus Erythematosus Market

8.3. Europe Systemic Lupus Erythematosus Market Snapshot

8.3.1. U.K. Systemic Lupus Erythematosus Market

8.3.2. Germany Systemic Lupus Erythematosus Market

8.3.3. France Systemic Lupus Erythematosus Market

8.3.4. Spain Systemic Lupus Erythematosus Market

8.3.5. Italy Systemic Lupus Erythematosus Market

8.3.6. Rest of Europe Systemic Lupus Erythematosus Market

8.4. Asia-Pacific Systemic Lupus Erythematosus Market Snapshot

8.4.1. China Systemic Lupus Erythematosus Market

8.4.2. India Systemic Lupus Erythematosus Market

8.4.3. Japan Systemic Lupus Erythematosus Market

8.4.4. Australia Systemic Lupus Erythematosus Market

8.4.5. South Korea Systemic Lupus Erythematosus Market

8.4.6. Rest of Asia Pacific Systemic Lupus Erythematosus Market

8.5. Latin America Systemic Lupus Erythematosus Market Snapshot

8.5.1. Brazil Systemic Lupus Erythematosus Market

8.5.2. Mexico Systemic Lupus Erythematosus Market

8.6. Rest of The World Systemic Lupus Erythematosus Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Eli Lilly & Company

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. GlaxoSmithKline

9.2.3. Bristl Myers Squibb Company

9.2.4. F. Hoffmann-La Roche AG

9.2.5. Pfizer Limited

9.2.6. Novartis AG

9.2.7. Sanofi SA

9.2.8. ImmuPharma PLC

9.2.9. AstraZeneca

9.2.10. Viatris Inc

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global Systemic Lupus Erythematosus Market, report scope

TABLE 2. Global Systemic Lupus Erythematosus Market estimates & forecasts by region 2018-2028 (USD Million)

TABLE 3. Global Systemic Lupus Erythematosus Market estimates & forecasts by Treatment Type 2018-2028 (USD Million)

TABLE 4. Global Systemic Lupus Erythematosus Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)

TABLE 5. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 6. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Systemic Lupus Erythematosus Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Systemic Lupus Erythematosus Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. U.S. Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 17. U.S. Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. Canada Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 19. Canada Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 20. Canada Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. UK Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 22. UK Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 23. UK Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. Germany Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 25. Germany Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 26. Germany Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. RoE Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 28. RoE Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 29. RoE Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. China Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 31. China Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 32. China Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. India Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 34. India Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 35. India Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. Japan Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 37. Japan Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 38. Japan Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. RoAPAC Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 40. RoAPAC Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 41. RoAPAC Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. Brazil Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 43. Brazil Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 44. Brazil Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Mexico Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 46. Mexico Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 47. Mexico Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. RoLA Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 49. RoLA Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 50. RoLA Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. Row Systemic Lupus Erythematosus Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 52. Row Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 53. Row Systemic Lupus Erythematosus Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. List of secondary sources, used in the study of global Systemic Lupus Erythematosus Market

TABLE 55. List of primary sources, used in the study of global Systemic Lupus Erythematosus Market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research